You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Stawowczyk M, Zhao Y, Pfeffer K, et al
1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1139